CALCA and osteoporosis: Teriparatide, the recombinant 1-34 fragment of human parathyroid hormone (rhPTH1-34) differs from the other therapeutic options for treating osteoporosis, such as bisphosphonates or calcitonin, which act by reducing bone reabsorption.